|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
02.12.25 - 15:03
|
Swan EndoSurgical Appoints Veteran Robotics and MedTech Leader Erik Todd as Chief Executive Officer (Business Wire)
|
|
|
BOSTON--(BUSINESS WIRE)--Swan EndoSurgical, an emerging leader in flexible endoluminal surgical robotics, today announced the appointment of Erik Todd as its Chief Executive Officer. Erik joins Swan following more than 25 years of leadership at Stryker Corporation, where he most recently served as Vice President and General Manager of the Robotics and Enabling Technologies division.
Erik brings deep experience scaling next-generation robotic platforms, building high-performance global engineering organizations, and driving innovation across endoscopy, minimally invasive surgery, and digital/AI-enabled enabling technologies.
Swan EndoSurgical is backed by Revival Healthcare Capital and Olympus Corporation and is focused on delivering a fully integrated flexible endoluminal robotic platform for complex gastrointestinal interventions.
“Erik is an accomplished and respected leader in surgical robotics,” said Justin Ballotta, Managing Director at Revival Healthcare Capital and Head of Post-Investment Value...
|
|
|
|
|
|
|
|
|
|
|
|
|
14.11.25 - 17:27
|
Stryker Aktie: Neuer Super-Roboter befeuert Wachstumsfantasie (Aktiencheck)
|
|
|
San Francisco (www.aktiencheck.de) - Stryker-Aktienanalyse von Wells Fargo Advisors:
Wells Fargo habe das Kursziel für die Aktie von Stryker Corp. (ISIN: US8636671013, WKN: 864952, Ticker-Symbol: SYK, NYSE-Symbol: SYK) von 452 auf 456 USD angehoben und das Rating "overweight" bestätigt. Die Bank verweise darauf, dass das Investorentreffen 2025 das Potenzial des Unternehmens für ein anhaltendes organisches Umsatzwachstum von 10% sowie ein zweistelliges EPS-Wachstum hervorgehoben habe. [mehr]...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
